LevitasBio Completes Series C Financing of $35 million
LevitasBio, Inc. announced it has completed Series C round financing of $35 million to advance its mission of providing powerful, industry-leading methods of cellular analysis.
The funding allows LevitasBio to accelerate its commercial success through the development of next generation hig ... more
This work will expand the ability to simultaneously monitor many processes in cells
Imagine the difficulty of visually keeping track of five people scattered throughout a stadium. Researchers perform far more amazing feats by simultaneously tracking many different cellular factors, but they need an expanded fluorescence toolkit to advance current capabilities.
Now, in a st ... more
Resolve Biosciences Secures $71 Million Series B Financing
Resolve Biosciences announced it has secured a $71 million Series B financing. The latest round of funding was led by Patient Square Capital and included participation from EDBI, PS Capital, Alafi Capital, and NRW.BANK, as well as other existing investors. The company has now raised more th ... more
UIC scientists use native chemical ligation to fuse peptides to tRNAs
Inside tiny cellular machines called ribosomes, chains of genetic material called messenger RNAs (mRNAs) are matched with the corresponding transfer RNAs (tRNAs) to create sequences of amino acids that exit the ribosome as proteins. Unfinished proteins are called nascent chainsm and they ar ... more
The development of the ZEISS Lattice Lightsheet 7 for the gentle 3D imaging of living cells was honored with the Federal President's Award for Technology and Innovation
The President of Germany, Frank-Walter Steinmeier, awarded the Deutscher Zukunftspreis 2022, The Federal President's Award for Technology and Innovation, to the team from ZEISS during a festive ceremony. The jury recognized the ZEISS experts Dr. Thomas Kalkbrenner, Dr. Jörg Siebenmorgen, an ... more
New facility supports customers and employees in the APAC region
Evident announced the opening of its new Asia-Pacific (APAC) headquarters in Singapore, marking its ongoing commitment to expand its business and operations in the APAC region.
The headquarters leads Evident’s strategy, technology and innovation in the APAC region, which includes operations ... more
Researchers have developed a novel method for antibiotic resistance testing that might transform microbial screening in clinical and research labs
Significant time is needed to determine the drug susceptibility profile of a bacterial infection. Now, researchers from Nara Institute of Science and Technology and collaborating partners have published reports on a technology that will dramatically speed up this otherwise slow process and ... more
An accurate picture of gene activity can provide the key to the development of new, targeted therapies
When searching for the causes of illnesses and developing new treatments, it is absolutely vital to have a precise understanding of the genetic fundamentals. Würzburg researchers have devised a new technique for this purpose.
Pathological processes are usually characterised by altered gene ... more
"In the future, additional tools will be integrated into the pipeline that will even enable us to predict the effects of a newly discovered mutation"
Algorithms developed at the Max Delbrück Center are able to quickly detect new SARS-CoV-2 variants in wastewater. But that’s not all: the tool, which Altuna Akalin and his colleagues have now presented in “Science of the Total Environment”, can also find other pathogens.
SARS-CoV-2 is one o ... more
The next step will be to investigate how DNA can be used to determine the age of animals that are still alive
They can live for more than 100 years and weigh up to 250 kilograms – Aldabra giant tortoises. Researchers at the University of Zurich have now decoded the genome of Aldabrachelys gigantea, one of only two remaining giant tortoise species worldwide. The findings will help to ensure the long ... more